David P. Langlois (DL 2319) SUTHERLAND ... - FDA Law Blog
David P. Langlois (DL 2319) SUTHERLAND ... - FDA Law Blog
David P. Langlois (DL 2319) SUTHERLAND ... - FDA Law Blog
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Case 1:09-cv-04665-<strong>DL</strong>C Document 49-2 Filed 03/30/2010 Page 17 of 451-121.1-129.117. Teva denies the allegations in Paragraph 117.118. Teva denies the allegations in Paragraph 118.119. Teva denies the allegations in Paragraph 119.120. Teva denies the allegations in Paragraph 120.121. Teva denies the allegations in Paragraph 121.COUNT XIII(INFRINGEMENT OF THE METHOD CLAIMS OF THE ‘090 PATENTUNDER 35 U.S.C. § 271(b))122. Teva incorporates by reference as if stated fully herein its responses to Paragraphs123. Teva denies the allegations in Paragraph 123.124. Teva denies the allegations in Paragraph 124.125. Teva denies the allegations in Paragraph 125.126. Teva denies the allegations in Paragraph 126.127. Teva denies the allegations in Paragraph 127.128. Teva denies the allegations in Paragraph 128.129. Teva denies the allegations in Paragraph 129.COUNT XIV(INFRINGEMENT OF THE METHOD CLAIMS OF THE ‘205 PATENT UNDER35 U.S.C. § 271(b))130. Teva incorporates by reference as if stated fully herein its responses to Paragraphs131. Teva denies the allegations in Paragraph 131.132. Teva denies the allegations in Paragraph 132.133. Teva denies the allegations in Paragraph 133.9067383.116
Change language